Scarica l'app Stockscreener
9.67
8.53%
0.76
Dopo l'orario di chiusura:
9.95
0.28
+2.90%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TNGX Giù?
Forum
Previsione
Tango Therapeutics Inc Borsa (TNGX) Ultime notizie
Tango Therapeutics appoints Sung Lee to board of directors By Investing.com - Investing.com Nigeria
Tango Therapeutics Adds Independent Director to Strengthen Governance - TipRanks
Tango Therapeutics Appoints Sung Lee to Board of Directors - GlobeNewswire
What analysts say about Tango Therapeutics Inc stockGap Fill Strategies & Superior Wealth Building - earlytimes.in
Tango Therapeutics (NASDAQ:TNGX) Sees Large Volume IncreaseShould You Buy? - MarketBeat
Tango Therapeutics (NASDAQ:TNGX) Nasdaq index Notes Liquidity Move - Kalkine Media
Tango Therapeutics Advances TNG462 Study for MTAP-deleted Tumors - MSN
Patterns Watch: How Tango Therapeutics Inc stock reacts to oil pricesDip Buying & Safe Entry Point Identification - moha.gov.vn
Tango Therapeutics (TNGX) Upgraded to Buy: Here's Why - MSN
3 Stocks With Strong Upside Potential for 2026 Gains - Tokenist
Biotech Stocks: Jefferies Names its 6 Top Picks for 2026 - Investing.com
Certain Common Stock of Tango Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 23-DEC-2025. - marketscreener.com
Certain Restricted Stock Units of Tango Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 23-DEC-2025. - marketscreener.com
Certain Pre-Funded Warrants of Tango Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 23-DEC-2025. - marketscreener.com
3 Biotech Stocks Wall Street Analysts Are Bullish on for 2026 - WV News
Tango Therapeutics, Inc. (NASDAQ:TNGX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Is Tango Therapeutics Inc. stock a smart buy before Fed meetingJuly 2025 Sentiment & Fast Entry High Yield Tips - Улправда
Will Tango Therapeutics Inc. stock benefit from commodity pricesJuly 2025 Trends & AI Driven Stock Reports - Улправда
Why Tango Therapeutics Inc. stock remains a top recommendationMarket Trend Report & Technical Pattern Based Signals - DonanımHaber
Will Tango Therapeutics Inc. stock deliver strong dividend growthProduct Launch & Real-Time Volume Analysis - DonanımHaber
Can Tango Therapeutics Inc. stock sustain market leadershipDay Trade & Verified Swing Trading Watchlist - DonanımHaber
Can Tango Therapeutics Inc. stock reach $100 price target2025 Sector Review & High Accuracy Swing Entry Alerts - Улправда
5 Biotech Stocks to Watch for Potential Upside - The Globe and Mail
Tango Therapeutics to Participate in 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Tango Therapeutics (NASDAQ:TNGX) Stock Price Up 7.6%Here's What Happened - MarketBeat
Is Tango Therapeutics (TNGX) Overvalued After a 200% One-Year Surge? A Fresh Look at Its Pricing - Yahoo Finance
Highs Report: Is Tango Therapeutics Inc stock a defensive play in 2025Portfolio Performance Report & Risk Managed Investment Signals - moha.gov.vn
Tango Therapeutics (NASDAQ:TNGX) Raised to Buy at Wall Street Zen - MarketBeat
Stempoint Capital LP Acquires Shares of 208,800 Tango Therapeutics, Inc. $TNGX - MarketBeat
Can Tango Therapeutics (TNGX) climb 37.28% to reach the level Wall Street analysts expect? - MSN
Tango Therapeutics (NASDAQ:TNGX) Stock Price Down 4.6%Should You Sell? - MarketBeat
Vivo Capital LLC Purchases Shares of 600,000 Tango Therapeutics, Inc. $TNGX - MarketBeat
Tango Therapeutics, Inc. $TNGX Stock Holdings Trimmed by XTX Topco Ltd - MarketBeat
Can Tango Therapeutics (TNGX) Climb 37.28% to Reach the Level Wall Street Analysts Expect? - Finviz
Tango Therapeutics CFO Beckman sells $25,281 in stock - MSN
Subdued Growth No Barrier To Tango Therapeutics, Inc. (NASDAQ:TNGX) With Shares Advancing 32% - simplywall.st
Geode Capital Management LLC Grows Position in Tango Therapeutics, Inc. $TNGX - MarketBeat
How interest rate cuts could boost Tango Therapeutics Inc. stockMarket Risk Analysis & Daily Profit Focused Screening - Newser
Stifel Initiates Coverage of Tango Therapeutics (TNGX) with Buy Recommendation - Nasdaq
Is Tango Therapeutics Inc. stock near bottom after declineJuly 2025 Spike Watch & Long-Term Safe Return Strategies - Newser
Stifel initiates Tango Therapeutics stock with Buy rating, $15 price target - Investing.com Nigeria
Stifel initiates Tango Therapeutics stock with Buy rating, $15 price target By Investing.com - Investing.com South Africa
Piper Sandler Healthcare Conference - marketscreener.com
Virtus Investment Advisers LLC Sells 38,979 Shares of Tango Therapeutics, Inc. $TNGX - MarketBeat
Tango Therapeutics (TNGX) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Can Tango Therapeutics Stock Hold Up When Markets Turn? - Trefis
Retail Trends: How interest rate cuts could boost Tango Therapeutics Inc stockRecession Risk & Fast Exit Strategy with Risk Control - moha.gov.vn
2.52%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):